New clues into a serious neurodegenerative disease

  Dementia encompasses a range of neurodegenerative conditions that lead to memory loss and cognitive deficiencies and affect some 55 million people worldwide. Yet despite its prevalence, there are few effective treatments, in part because scientists still don’t understand how exactly dementia arises on a cellular and molecular level.  

Related Keywords

California ,United States ,Canada ,San Francisco ,Canadian ,William Seeley ,Robert Farese Jr ,Shubham Singh ,Salvatore Spina ,Tobias Walther ,Alexander Fischer ,Pedro Malia ,Geetika Aggarwal ,Lea Grinberg ,Alissa Nana ,Michal Surma ,Joao Paulo ,Sebastian Boland ,Ruth Richards ,Wade Harper ,Lipotype Gmb ,Sharan Swarup ,Yohannes Ambaw ,Andrew Nguyen ,Christian Klose ,University Of California ,Nature Communications ,Harvard Chan School ,Department Of Cell Biology ,National Institutes Of Health ,Interline Therapeutics Inc ,Harvard Medical School ,Antora Bio Inc ,Canadian Institutes Of Health Research ,Walther ,Saint Louis University School Of Medicine ,Farese Walther Lab ,Blavatnik Institute ,Caraway Therapeutics Inc ,Howard Hughes Medical Institute ,Chan School ,Public Health ,Natalie Vallee Professor ,Molecular Pathology ,Cell Biology ,Robert Farese ,Walther Lab ,Saint Louis University School ,Bluefield Project ,National Institutes ,Google Ventures ,Third Rock Ventures ,Aligning Science Across Parkinson ,Canadian Institutes ,Health Research ,Howard Hughes Medical ,Caraway Therapeutics ,Interline Therapeutics ,Antora Bio ,